# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009575
Filing Date
2025-05-12
Accepted
2025-05-12 08:30:39
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1139404
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 14651
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 14771
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 5419
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 5494
| Complete submission text file | 0001641172-25-009575.txt |  | 6343775

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | lixt-20250331.xsd | EX-101.SCH | 47609
7 | XBRL CALCULATION FILE | lixt-20250331_cal.xml | EX-101.CAL | 32684
8 | XBRL DEFINITION FILE | lixt-20250331_def.xml | EX-101.DEF | 245256
9 | XBRL LABEL FILE | lixt-20250331_lab.xml | EX-101.LAB | 419081
10 | XBRL PRESENTATION FILE | lixt-20250331_pre.xml | EX-101.PRE | 328986
61 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 957140

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 25932742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)